Similar combination experiments in infant MLL-r ALL cells overexpressing wild-type FLT3 were performed, and again synergy was observed using chemotherapy first, followed by lestaurtinib (108). This evidence concerns the gene FLT3 and acute lymphoblastic leukemia.